Development asset linked to MEDICE Arzneimittel Pütter in public FDA and regional records.
pharma · acute pharyngitis
MEDICE Arzneimittel Pütter
Medice Arzneimittel Pütter GmbH & Co. KG
MEDICE Arzneimittel Pütter drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Company details
- Status
- Public
- HQ
- Iserlohn, DE
- Founded
- 1949
- Employees
- 600
- Programs
- 3
- Drugs
- 6
- Patents
- 0
MEDICE Arzneimittel Pütter pipeline
Portfolio lens on 6 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
MEDICE Arzneimittel Pütter drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to MEDICE Arzneimittel Pütter in public FDA and regional records.
-
Development asset linked to MEDICE Arzneimittel Pütter in public FDA and regional records. Molecular target: Sodium-dependent dopamine transporter.
- Target
- Sodium-dependent dopamine transporter
- Mechanism
- Dopamine transporter releasing agent
-
Development asset linked to MEDICE Arzneimittel Pütter in public FDA and regional records.
-
Development asset linked to MEDICE Arzneimittel Pütter in public FDA and regional records.
-
Development asset linked to MEDICE Arzneimittel Pütter in public FDA and regional records.